Phase III Study to Assess Long-Term (52-Week) Safety and...

  • Main
  • 2015 / 06
  • Phase III Study to Assess Long-Term (52-Week) Safety and...

Phase III Study to Assess Long-Term (52-Week) Safety and Efficacy of Mirabegron, a β 3 -Adrenoceptor Agonist, in Japanese Patients with Overactive Bladder

YAMAGUCHI, Osamu, IKEDA, Yasushi, OHKAWA, Sumito
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
LUTS: Lower Urinary Tract Symptoms
DOI:
10.1111/luts.12107
Date:
June, 2015
File:
PDF, 1.14 MB
english, 2015
Conversion to is in progress
Conversion to is failed